Asthma-related hospitalizations after implementing SABA-free asthma management with a maintenance and anti-inflammatory reliever regimen

Overreliance on short-acting β(2)-agonists (SABA) has been a common feature of asthma management globally for at least 30 years. However, given the evidence against the long-term use of SABA, including potentially increased risk of exacerbations, emergency room visits, overall healthcare resource ut...

Descripción completa

Detalles Bibliográficos
Autores principales: Nannini, L. J., Neumayer, N. S., Brandan, N., Fernández, O. M., Flores, D. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361757/
https://www.ncbi.nlm.nih.gov/pubmed/35959199
http://dx.doi.org/10.1080/20018525.2022.2110706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361757/
https://www.ncbi.nlm.nih.gov/pubmed/35959199
http://dx.doi.org/10.1080/20018525.2022.2110706

Ejemplares similares